Lanean...
The emerging potential for network analysis to inform precision cancer medicine
Precision cancer medicine promises to tailor clinical decisions to patients using genomic information. Indeed, successes of drugs targeting genetic alterations in tumors, such as imatinib that targets BCR-ABL in chronic myelogenous leukemia, have demonstrated the power of this approach. However biol...
Gorde:
| Argitaratua izan da: | J Mol Biol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097914/ https://ncbi.nlm.nih.gov/pubmed/29908887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmb.2018.06.016 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|